The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
If I interpret the language correctly (I am a native English speaker, but DoH seems to write in something else) the most obvious potential for devilry is in the tariff-setting. If it's slightly wrong, some activities will be more profitable than others. In a PbR system, who's going to want to do the less profitable types of clinical work?
So if you have the 'wrong' type of illness, tough luck!
No idea if there's a mechanism to correct for this. NuLab's managerial abilities in other fields suggests not.
by gmoke - Aug 25
by gmoke - Aug 19
by Oui - Sep 10
by Oui - Sep 9
by Oui - Sep 87 comments
by Oui - Sep 8
by Oui - Sep 6
by Oui - Sep 4
by Oui - Sep 1
by Oui - Aug 31
by Oui - Aug 254 comments
by Oui - Aug 23
by Oui - Aug 21
by Oui - Aug 20
by Oui - Aug 18
by Oui - Aug 16
by Oui - Aug 11